Juniper Pharm Inc (JNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-1999 | 06-1999 | 03-1999 | 12-1998 | 09-1998 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 380 | 1,310 | 140 | -13,860 | -8,580 |
| Depreciation Amortization | 730 | 490 | 260 | 990 | 730 |
| Other Working Capital | -2,670 | -4,260 | -3,410 | 3,690 | 1,010 |
| Other Operating Activity | 50 | 40 | 10 | 1,690 | 450 |
| Operating Cash Flow | $-1,510 | $-2,420 | $-3,000 | $-7,490 | $-6,390 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -70 | -50 | -4 | -260 | -280 |
| Net Acquisitions | 0 | 0 | -100 | 0 | 0 |
| Other Investing Activity | -4,700 | -100 | 4 | -4,620 | -4,600 |
| Investing Cash Flow | $-4,770 | $-150 | $-100 | $-4,880 | $-4,880 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -330 | -260 | -180 | 0 | 0 |
| Other Financing Activity | 5,910 | 5,810 | 5,930 | 10,350 | 10,350 |
| Financing Cash Flow | $5,580 | $5,550 | $5,750 | $10,350 | $10,350 |
| Exchange Rate Effect | 20 | 10 | -40 | 70 | 30 |
| Beginning Cash Position | 310 | 310 | 310 | 2,250 | 2,250 |
| End Cash Position | 4,220 | 3,290 | 2,920 | 310 | 1,360 |
| Net Cash Flow | $3,910 | $2,980 | $2,600 | $-1,940 | $-890 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,510 | -2,420 | -3,000 | -7,490 | -6,390 |
| Free Cash Flow | -1,510 | -2,420 | -3,000 | -7,490 | -6,390 |